EUVIMEDEUVIMED entdecken
Open Access

Performance of eight commercial immunoassays for the detection of cytomegalovirus-specific IgM antibodies in pregnancy – no test fits all needs

Anja Daiminger, Robert Beck, Simone Exler, Uwe Bartelt, Martin Enders iD

Journal of Clinical Microbiology · 2024

DOI: 10.1128/jcm.01407-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Anja Daiminger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Prof. Gisela Enders and Colleagues, MVZ, Stuttgart, Germany. Hauptthemen laut MEDLINE: Pregnancy Complications, Infectious, Cytomegalovirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Detection of cytomegalovirus (CMV)-specific immunoglobulin M (IgM) antibodies as first-line serologic diagnosis plays an important role in identifying CMV primary infection during pregnancy. The performance characteristics of eight commercially available CMV IgM assays were compared. Sensitivity and IgM antibody kinetics were assessed using 100 acute phase and follow-up sera from 39 pregnant women with a well-defined onset of CMV primary infection. Specificity was analyzed using 50 well-characterized serum samples from pregnant women not infected or latently infected with CMV and from patients with other acute infections. Until 12 weeks after the onset of primary infection, four assays showed sensitivities of 100%, whereas the others had individual gaps to detect all primary infections in this time period. All assays showed a time-dependent decrease of IgM levels. More than 12 weeks after the onset of infection, the IgM-positive rates varied considerably between tests. The specificity was between 92% and 98% in all but one assay. The observed differences in the performance characteristics must be taken into account in CMV screening and diagnosis of primary infection during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy Complications, InfectiousCytomegalovirus InfectionsPregnancyFemaleHumansCytomegalovirusImmunoassayImmunoglobulin MAntibodies, Viral

Stichwörter der Autor:innen

IgM serologycytomegaloviruspregnancyprimary infectionscreening

Substanzen

Immunoglobulin MAntibodies, Viral

Autor:innen und Institutionen

  • Laboratory Prof. Gisela Enders and Colleagues, MVZ, Stuttgart, Germany.

ORCID-Profile: Martin Enders

Zitieren

APA

Daiminger, A., Beck, R., Exler, S., Bartelt, U., & Enders, M. (2024). Performance of eight commercial immunoassays for the detection of cytomegalovirus-specific IgM antibodies in pregnancy – no test fits all needs. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01407-23

Vancouver

Daiminger A, Beck R, Exler S, Bartelt U, Enders M. Performance of eight commercial immunoassays for the detection of cytomegalovirus-specific IgM antibodies in pregnancy – no test fits all needs. Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.01407-23

BibTeX
@article{Daiminger2024,
  author = {Daiminger, Anja and Beck, Robert and Exler, Simone and Bartelt, Uwe and Enders, Martin},
  title = {Performance of eight commercial immunoassays for the detection of cytomegalovirus-specific IgM antibodies in pregnancy – no test fits all needs},
  journal = {Journal of Clinical Microbiology},
  year = {2024},
  doi = {10.1128/jcm.01407-23}
}
Kostenlos starten →